JPM Stock UPDATES JP Morgan Chase & Co (JPM) 60.48 11/02/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
JP Morgan Chase & Co (JPM) 60.48 $JPM

Citigroup Restates Q3 Earnings on $600M Legal Charges - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 5:22PM CDT
Following the ongoing regulatory inquiries and investigations, Citigroup Inc. (C) restated its third-quarter 2014 earnings, giving effect to additional legal charges worth $600 million.
BCS: 15.40 (+1.02), JPM: 60.48 (+1.09), C: 53.53 (+0.38), HSBC: 51.02 (+0.57), RBS: 12.43 (+0.69), UBS: 17.38 (+0.29)

5 Things Visa Inc.'s Management Wants You to Know
Jordan Wathen, The Motley Fool - Motley Fool - Fri Oct 31, 8:13AM CDT
Visa shares rocketed after earnings. It was a bevy of good news -- cross-border transactions were up, revenue was up, and the company's growth looked better than it has in quite some time. The good news only continued into the company's fiscal...
V: 241.43 (+4.78), JPM: 60.48 (+1.09), BAC: 17.16 (+0.13), MA: 83.75 (+0.62)

Why JPMorgan Chase & Co. Stock Is Flat This Year
Kingkarn Amjaroen, The Motley Fool - Motley Fool - Fri Oct 31, 8:08AM CDT
JPMorgan 's stock return this year is nothing to get excited about: roughly flat for 2014 (and competitors didn't do much better). Wall Street banks were clearly not investors' favorites in 2014. However, JPMorgan's paltry stock return might not...
JPM: 60.48 (+1.09)


Japan's huge pension fund to boost share purchases
By ELAINE KURTENBACH - AP - Fri Oct 31, 6:13AM CDT
TOKYO (AP) — Japan's $1.1 trillion public pension fund on Friday approved a plan to double its holdings of shares and cut back sharply on bonds to help improve investment returns and meet its obligations to a swelling number of retirees.
JPM: 60.48 (+1.09)

Hedge Fund Billionaires Support New York Attorney General Schneiderman
at The Street - Fri Oct 31, 5:10AM CDT
Chanos, Einhorn, Soros and Paulson are some of the prominent hedge fund names who are backing Schneiderman's 2014 reelection campaign.
JPM: 60.48 (+1.09), BAC: 17.16 (+0.13)

Citi cuts earnings due to regulatory probes
AP - Thu Oct 30, 5:37PM CDT
NEW YORK (AP) — Citigroup has slashed its third-quarter earnings by $600 million, saying that recent investigations by regulators have altered the results it reported earlier this month.
JPM: 60.48 (+1.09), C: 53.53 (+0.38), BAC: 17.16 (+0.13)

Fitch Rates J.P. Morgan Mortgage Trust 2014-5
Business Wire - Thu Oct 30, 3:03PM CDT
Fitch Ratings assigns the following ratings to J.P. Morgan Mortgage Trust 2014-5 (JPMMT 2014-5):
JPM: 60.48 (+1.09)

Fitch Rates J.P. Morgan Madison Avenue Securities Trust Series 2014-1
Business Wire - Thu Oct 30, 2:14PM CDT
Fitch Ratings has assigned the following rating and Rating Outlook to JPMorgan Chase Bank's inaugural risk transfer transaction J.P. Morgan Madison Avenue Securities Trust Series 2014-1:
JPM: 60.48 (+1.09)

Chase Receives J.D. Power's Top Rank for Small Business Banking in Northeast and West Regions for 2014
Business Wire - Thu Oct 30, 9:00AM CDT
Chase ranked highest in customer satisfaction for small business banking in the Northeast and West Regions in the 2014 J.D. Power study released today. For the second year, small businesses in the Western United States ranked Chase highest. In the Midwest and South Regions, Chase ranked second. Overall the bank ranked ahead of America's 15 largest banks.(1)
JPM: 60.48 (+1.09)

Markit to Present at the J.P. Morgan Ultimate Services Investor Conference
Business Wire - Thu Oct 30, 8:42AM CDT
Markit Ltd. (Nasdaq: MRKT), a leading global diversified provider of financial information services, today announced that Lance Uggla, chairman and chief executive officer, will present at the J.P. Morgan Ultimate Services Investor Conference in New York on Wednesday November 12th 2014 at 2.45pm (EST).
JPM: 60.48 (+1.09), MRKT: 25.54 (+1.13)

David Bloom Joins Wilmington Trust as Managing Director for Wealth Advisory
PRWeb - Thu Oct 30, 8:08AM CDT
Wilmington Trust hired David J. Bloom, J.D., CFP(R) as managing director and senior private client advisor in the firm's Wealth Advisory division to serve its growing base of high-net-worth clients in the Greater Philadelphia region. He is based in Wilmington Trust's office in Villanova, Pa.
JPM: 60.48 (+1.09)

New JPMorgan Chase & Co. Report Reveals Solutions to Fill Vital Healthcare and Technology Jobs in New York City
Business Wire - Thu Oct 30, 8:00AM CDT
JPMorgan Chase & Co. today released the first in a series of reports that lays out a specific roadmap for addressing the mismatch between the needs of employers and the skills of current job seekers. Specifically, this report provides a comprehensive look at available middle-skill healthcare and technology jobs in New York City and offers data-driven steps city policy makers, community colleges, training providers and private sector employers can take to fill these critical, good paying industry roles.
JPM: 60.48 (+1.09)

Stocks With Monthly Dividends: Chambers Street Properties
Matthew Frankel, The Motley Fool - Motley Fool - Thu Oct 30, 7:15AM CDT
Chambers Street Properties is a real estate investment trust, or REIT, that owns and operates industrial and office properties. The company leases properties to a diverse group of high-quality tenants, with the main goal of providing a steady,...
CSG: 8.21 (+0.10), AMZN: 305.46 (+6.39), JPM: 60.48 (+1.09), CLX: 99.50 (+0.90), RTN: 103.88 (+0.68)

'Fast Money' Recap: Goodbye to QE, Hello Financial Stocks
at The Street - Thu Oct 30, 4:00AM CDT
The trading panel discussed the end of quantitative easing, retail stocks and 3-D printing.
PNRA: 161.64 (-0.71), FB: 74.99 (+0.88), C: 53.53 (+0.38), NNA: 3.17 (+0.09), BAC: 17.16 (+0.13), DWA: 22.28 (+0.25), HPQ: 35.88 (+0.56), GS: 189.99 (+3.02), JPM: 60.48 (+1.09), QQQ: 101.40 (+1.38), TRN: 35.71 (+1.20), SSYS: 120.36 (+4.95), FFIV: 122.98 (+1.20), COST: 133.37 (+0.37), TRLA: 46.65 (+2.31), TWTR: 41.47 (-0.33), SNY: 46.24 (+0.54), WTW: 26.05 (+0.49)

Boot Barn Holdings, Inc. Prices Its Initial Public Offering
Business Wire - Wed Oct 29, 5:15PM CDT
Boot Barn Holdings, Inc. ("Boot Barn" or the "Company" announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $16.00 per share. The shares will be listed on the New York Stock Exchange and will trade under the ticker symbol "BOOT" beginning on October 30, 2014. All of the shares in the offering are being offered by Boot Barn. In addition, Boot Barn has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares from the Company. The closing of the offering is expected to occur on November 4, 2014, subject to the satisfaction of customary closing conditions.
JPM: 60.48 (+1.09), BOOT: 17.75 (+0.30)

Chimerix Announces Commencement of Public Offering of Common Stock
GlobeNewswire - Wed Oct 29, 4:30PM CDT
Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it intends to offer and sell, subject to market and other conditions, approximately $105,000,000 of its common stock in an underwritten public offering. In connection with this offering, Chimerix expects to grant the underwriters a 30-day option to purchase up to approximately $15,750,000 of additional shares of its common stock. Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering, and Cowen and Company, LLC, Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated are acting as co-lead managers for the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the size or terms of the offering. Chimerix anticipates using the net proceeds from the offering to fund its research and development efforts and for general corporate purposes, including working capital.
CMRX: 31.04 (+1.15), JPM: 60.48 (+1.09), MS: 34.95 (+0.43)

The Future of Bank Profits (Spoiler Alert: Things Don’t Look Good)
John Maxfield, The Motley Fool - Motley Fool - Wed Oct 29, 2:33PM CDT
It should come as no surprise that banks are not as profitable today as they were before the financial crisis. Between 1994 and 2006, the bank industry's average return on equity typically fluctuated between 12% and 15%. Now it appears to be settling...
JPM: 60.48 (+1.09), C: 53.53 (+0.38), BAC: 17.16 (+0.13)

Upcoming Conferences, Quarterly Dividend, Earnings, and Recognition - Research Reports on JPMorgan Chase, Bank of America, Citigroup, Wells Fargo and Itau Unibanco
PR Newswire - Wed Oct 29, 7:40AM CDT
Today, Analysts Review released its research reports regarding JPMorgan Chase & Co. (NYSE: JPM), Bank of America Corporation (NYSE: BAC), Citigroup Inc. (NYSE: C), Wells Fargo & Company (NYSE: WFC) and Itau Unibanco Holding S.A. (NYSE: ITUB). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7521-100free.
JPM: 60.48 (+1.09), C: 53.53 (+0.38), WFC: 53.09 (+0.63), BAC: 17.16 (+0.13), ITUB: 14.76 (+0.01)

American HealthCare Lending to Demonstrate Leading Patient Financing Platform at the MGMA 2014 Annual Conference
PRWeb - Tue Oct 28, 4:15PM CDT
American HealthCare Lending (AHCL) the leading non-recourse patient financing platform serving health systems, physician groups, surgical centers, and other healthcare providers, will exhibit their innovative financing platform at the MGMA Annual Conference held October 26-29 in Las Vegas. The MGMA Annual Conference brings healthcare providers together to learn and collaborate about new methods to deliver the best possible patient care.
JPM: 60.48 (+1.09)

Look for Shares of JPMorgan Chase to Potentially Pullback after Yesterday's 1.69% Rise
Comtex SmarTrend(R) - Tue Oct 28, 3:51PM CDT
JPMorgan Chase (NYSE:JPM) traded in a range yesterday that spanned from a low of $58.81 to a high of $59.69. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $58.79 on volume of 13.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JPM: 60.48 (+1.09)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 127

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 83

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 13

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 63

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 98

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 81

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 88

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

DXC Technology to Announce Q3 Fiscal 2026 Earnings Soon

Updated Category News Views 159

DXC Technology Announces Upcoming Q3 Fiscal 2026 Earnings DXC Technology (NYSE: DXC), a prominent leader in enterprise technology and innovation, has set a date for the release of its financial results for the third quarter of fiscal 2026. The earnings report will be published on a Thursday, after the market closes, providing stakeholders with insights into the company's...

Continue Reading
Jim Cramer Highlights Mettler-Toledo as a Buy Amid Market Woes

Updated Category News Views 188

Jim Cramer Recommends Mettler-Toledo International Inc. On a recent episode of CNBC's popular program, Jim Cramer advised investors to consider buying shares of Mettler-Toledo International Inc. (NYSE: MTD). Cramer's endorsement came after the company reported impressive quarterly results, showcasing strong financial health. Strong Earnings Report from Mettler-Toledo...

Continue Reading
Strategic Alliance Between Vireo and Curio Enhances Growth Opportunities

Updated Category News Views 110

Strategic Partnership Announced Leading cannabis companies Vireo Growth Inc. and Curio Wellness have forged a partnership aimed at leveraging shared resources to tap into the burgeoning cannabis market. This collaboration marks an exciting new chapter for both companies as they work to introduce innovative health and wellness products to consumers. Vireo Growth Inc.: A...

Continue Reading
Anoto Group Reports Second Quarter Results 2024

Updated Category News Views 137

Overview of the Interim Report for 2024 The interim report covering January to June 2024 provides important insights into Anoto Group AB's operations and financial health. Anoto Group continues to be a leader in technology, particularly in optical recognition and digital writing. This report emphasizes key financial metrics and the company's strategic initiatives in a...

Continue Reading
AAOS: Orthobiologics' Future Anchored in Solid Science

Updated Category News Views 9

The Challenge of Orthobiologics: Hype vs. Science Amid the buzz around orthobiologics, it's high time folks face reality: enthusiasm doesn't equal evidence. Dr. Jason Dragoo, the symposium co-chair, hit the nail right on the head—the medical community's chief duty is to sift the wheat from the chaff when it comes to flashy new treatments that lack scientific backing....

Continue Reading